EQUIPO DE FOTOTERAPIA CLINICA
productos relacionados
Lamparas/Focos del Repuesto
Dispositivos de medición
Proteccion para los ojos
Tratamiento de acne TRU-BLU
FOTOTERAPIA EN PRACTICAA
Sayuda para Sus Pacientes
Fototerapia vs Biologicos
Estudio de Psoralen y UVA
Estudio de Vitiligo
Fototerapia vs Biologicos
Preguntas Frecuentes de Médicos
UNIDAD PARA paCientES EN CASA
Cabina Plegable del Hogar Foldalite
Tratamiento manual para manchas
Paneles de luz UVB para el hogar
NOTICIAS
Productos nuevos para el pais
Próximas ferias comerciales
EXPERTOS EN FOTOTERAPIA
Escuche De Nuestros Consumidores
Acerca de National Biological
¿Necesita ayuda?
Mapa del Sitio
Contactenos
800-338-5045


PATIENTS     PHYSICIANS     THIRD PARTY PAYERS     HOME    

Randomized Double Blind Trial of Treatment of Vitiligo
     Efficacy of Psoralen-UVA Therapy vs Narrowband UVB Therapy

Randomized Double Blind Trial of Treatment of Vitiligo: Efficacy of Psoralen-UVA Therapy vs Narrowband UVB Therapy. Yones SS, Der D, Palmer RA, Garibaldinos TM, Hawk JLM. Arch Dermatol 2007; 143:578-84.                                           Read Full Article
OBJECTIVE: To compare the efficacy of oral psoralen- UV-A (PUVA) with that of narrowband- UV-B (UVB de Banda Estrecha) phototherapy in patients with nonsegmental vitiligo.
DESIGN: Double-blind randomized study.
SETTING: Phototherapy unit in a university hospital.
PATIENTS:
Fifty-six patients with nonsegmental vitiligo.
INTERVENTIONS: 
Twice-weekly therapy with PUVA or UVB de Banda Estrecha.
MAIN OUTCOME MEASURES:
The change in body surface area affected by vitiligo and the color match of repigmented skin compared with unaffected skin were assessed after 48 sessions of therapy, at the end of the therapy course, and 12 months after the end of therapy.
RESULTS: 
The results in the 25 patients each in the PUVA and UVB de Banda Estrecha groups who began therapy were analyzed.  The median number of treatments was 47 in the PUVA-treated group and 97 in the UVB de Banda Estrecha group (P=.03); we suspect this difference was because of differences in efficacy and adverse effects between the two modalities, such that patients in the UVB de Banda Estrecha group wanted a longer course of treatment. At the end of therapy, 16 (64%) of 25 patients in the UVB de Banda Estrecha group showed greater than 50 % improvement in body surface area affected compared with 9 (36%) of 25 patients in the PUVA group. The color match of repigmented skin was excellent in all patients in the UVB de Banda Estrecha group but in only 11 (44%) of those in the PUVA group (P<.001). In patients who completed 48 sessions, the improvement in body surface area affected by vitiligo was greater with UVB de Banda Estrecha therapy than with PUVA therapy (P<.007). Twelve months after the cessation of therapy, the superiority of UVB de Banda Estrecha tended to be maintained.
CONCLUSIONS
In the treatment of nonsegmental vitiligo, UVB de Banda Estrecha therapy is superior to oral PUVA therapy.

Read Full Article